12.04.13
MHRA’s five-year plan to better regulate medicines and devices
Science and research will be prioritised as part of the Medicines and Healthcare Regulatory Agency (MHRA)’s new five-year corporate plan.
From this month, the MHRA has started the transfer of the National Institute for Biological Standards and Control (NISBC) from the Health Protection Agency.
The new plan highlights the aim to lead global research and to bring new medicines to market. A regulatory excellence programme is also launched to cut red tape in the industry.
MHRA chief executive, Professor Sir Kent Woods said: “Our corporate plan sets out our key aim of protecting and enhancing the health of millions of people through better regulation of medicines and medical devices and promoting innovation.
“We have an exciting five years ahead with the introduction of the National Institute for Biological Standards and Control (NISBC) to the MHRA family this year and we are focused on achieving our aim of being a world leader in supporting science and research.”
Tell us what you think – have your say below, or email us directly at [email protected]